Breadcrumb Home Technology September 10, 2018 01:00 AM News from other sources Modern Healthcare Tweet Share Share Email More Print PharmaceuticalsConsort, Opiant to develop nasal spray for opioid overdose treatment | ReutersThe two companies will work together on a nasal-spray version of nalmefene. Opiant received a $7.4 million grant from the NIH earlier this year to develop the treatment.TechnologyAmazon and Apple are getting into medical clinics — here's why | CNBCThe companies want to keep healthcare costs down and test new products—and make some money too.Opternative launches voice-based, smartphone-only vision test | MobihealthnewsThe voice recognition software comes from Google, IBM Watson, and Microsoft.Medical devicesPayers join new FDA program to expedite medical device coverage | Health Data ManagementBlueCross BlueShield Association, CareFirst BlueCross BlueShield, Humana, Kaiser Permanente and United Health Group are meeting with the FDA to speed up the regulatory process.In other newsSerena Williams vs. Naomi Osaka: How the U.S. Open descended into chaos | The New York Times"I don't cheat to win, I'd rather lose. I'm just letting you know," Williams told the chair umpire. Letter to the Editor Send us a letter Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print. Recommended for You Sponsored Content View the discussion thread.